The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s prenatal testing and newborn screening market report forecasts the prenatal testing and newborn screening market size to grow to $8.87 Billion by 2027, with a CAGR (compound annual growth rate) of almost 12%.

Learn More On The Prenatal Testing And Newborn Screening Market Report 2023 – https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market

Prenatal Testing And Newborn Screening Market Size Forecast
The global prenatal testing and newborn screening market is expected to grow from $5.04 billion in 2022 to $5.65 billion in 2023 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The prenatal testing & newborn screening market is expected to grow from $8.87 billion in 2027 at a CAGR of 11.9%.

North America held the largest prenatal testing and newborn screening market share.

Key Prenatal Testing And Newborn Screening Market Driver ­– Increase In The Prevalence Of Genetic Diseases In Infants
According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anaemia, Haemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anaemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, and India. According to data published in 2020 by the Centres for Disease Control and Prevention, a national public health agency of the United States, 5,568 babies were affected by Trisomy 21 (Down syndrome), 1,187 babies were affected by Trisomy 18 (Edwards syndrome), and 531 babies were affected by Trisomy 13 (Patau syndrome). The high prevalence of genetic diseases in infants boosted the demand for prenatal testing and newborn screening market.

Request for A Sample Of The Global Prenatal Testing And Newborn Screening Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Key Prenatal Testing And Newborn Screening Market Trend – Launching Machine Learning And AI
Artificial intelligence (AI) is the simulation of human intelligence in machines. Machine learning is a part of AI. Machine learning and AI help companies in the prenatal testing and newborn screening market to conduct a detailed analysis of all relevant data, provide insights about different diseases, and offer a more accurate evaluation of tissue samples. For instance, In September 2021, Sema4, a US-based AI-driven genomic and clinical data intelligence platform company, launched Sema4 Elements. Sema4 Elements are genetic solutions that are information-driven, digital tools for patients and providers, and services that let doctors manage patients holistically throughout their journeys with reproductive and generational health, using artificial intelligence.

Prenatal Testing And Newborn Screening Market Segment
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers

Prenatal Testing And Newborn Screening Market Major Players and Strategies
Major players in the prenatal testing and newborn screening market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagnostics and Baebies.

In March 2020, Thermo Fisher Scientific Inc. announced its decision to acquire Qiagen for $11.5 billion. Thermo Fisher has a specialty diagnostics capability, that includes allergy, autoimmunity, transplant diagnostics, and oncology testing. The acquisition is expected to complement Thermo Fisher’s genetic analysis and bioscience capabilities. Qiagen is a Germany-based genetic tester that was founded in 1984 and operates more than 35 offices in over 25 countries.

The Prenatal Testing And Newborn Screening Global Market Report 2023 covers regional data on prenatal testing and newborn screening market size, prenatal testing and newborn screening market trends and drivers, opportunities, strategies, and prenatal testing and newborn screening market competitor analysis. The countries covered in the prenatal testing and newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Prenatal testing and newborn screening tests are diagnostic tests to detect any possible birth defects that may be there in the baby. These are useful in determining the health of the baby.

View More Reports Related To The Prenatal Testing And Newborn Screening Market –
Noninvasive Prenatal Testing Global Market Report 2023
Genetic Testing Global Market Report 2023
Parenteral Nutrition Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: